ANTHONY P. ADAMIS

Insider Reports History

Location
New York, NY
Signature
/s/ Andrew Oxtoby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANTHONY P. ADAMIS:

Company Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 4,000 $41,189 $10.30 23 Jun 2024 Direct
EyePoint Pharmaceuticals, Inc. Director Restricted Stock Units 2,000 $20,594 $10.30 23 Jun 2024 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 25,014 05 Jan 2024 Direct
Kalaris Therapeutics, Inc. Director Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct

Insider Reports Filed by ANTHONY P. ADAMIS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KLRS Kalaris Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director 11 Apr 2025, 16:52
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 2 $0 4 Director 18 Mar 2025, 17:37
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 0 $0 3 Director 18 Mar 2025, 17:14
EYPT EyePoint Pharmaceuticals, Inc. 23 Jun 2024 2 $0 4 Director 25 Jun 2024, 16:16
EYPT EyePoint Pharmaceuticals, Inc. 05 Jan 2024 1 $0 4 Director 09 Jan 2024, 20:53
EYPT EyePoint Pharmaceuticals, Inc. 23 Jun 2023 2 $0 4 Director 26 Jun 2023, 17:10
EYPT EyePoint Pharmaceuticals, Inc. 20 Jun 2023 2 $0 4 Director 22 Jun 2023, 09:18
EYPT EyePoint Pharmaceuticals, Inc. 23 Jun 2022 2 $0 4 Director 27 Jun 2022, 16:38
EYPT EyePoint Pharmaceuticals, Inc. 23 Jun 2022 0 $0 3 Director 27 Jun 2022, 16:37